Express Scripts (ESRX) Tops Q3 EPS by 1c

Express Scripts (NASDAQ: ESRX) reported Q3 EPS of $1.45, $0.01 better than the analyst estimate of $1.44. Revenue for the quarter came in at $25.22 million versus the consensus estimate of $26.38 million.

Express Scripts sees Q4 2015 EPS of $1.54-$1.58, versus the consensus of $1.54.

For earnings history and earnings-related data on Express Scripts (ESRX) click here.

You May Also Be Interested In

• Nebius soars on second quarter revenue beat
• Arbutus Biopharma (ABUS) Reports In-Line Q2 EPS
• LiqTech International (LIQT) Reports In-Line Q2 EPS